Caroline Springs, Australia

Sue Pallich




Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Yarraville, AU (2012)
  • Caroline Springs, AU (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Inventive Mind of Sue Pallich: Revolutionizing Macromolecule Modifications

Introduction: Sue Pallich, based in Caroline Springs, AU, is a prolific inventor with a keen eye for molecular innovation. With an impressive portfolio of two patents, his groundbreaking work in modifying macromolecules has the potential to reshape the field of pharmaceuticals and biotechnology.

Latest Patents: Sue Pallich's latest patents focus on a modified macromolecule with a controlled terminal group stoichiometry. These innovations involve a detailed surface layer, subsurface layer, and multiple terminal groups. The macromolecules include a first terminal group derived from a pharmaceutically active agent and a second terminal group chosen to alter the agent's pharmacokinetics.

Career Highlights: Currently employed at Starpharma Pty Limited, Sue Pallich continues to drive forward cutting-edge research and development in the realm of molecular modifications. His dedication to enhancing the effectiveness and efficiency of pharmaceutical compounds is truly commendable.

Collaborations: Within the dynamic environment of Starpharma Pty Limited, Sue Pallich collaborates with industry peers such as Benjamin James Boyd and Lisa Michelle Kaminskas. This teamwork fosters innovation and propels the advancement of novel solutions in the pharmaceutical landscape.

Conclusion: Sue Pallich stands as a testament to the power of inventive thinking and relentless pursuit of scientific excellence. His contributions to the field of macromolecule modifications exemplify a visionary approach towards enhancing drug delivery and efficacy. With a promising career ahead, Sue Pallich continues to inspire and innovate within the realm of molecular research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…